HSA — authorised 13 June 2022
- Marketing authorisation holder: ALNYLAM PHARMS INC
- Status: likely_approved
🇸🇬 Amvuttra in Singapore
HSA authorised Amvuttra on 13 June 2022
Marketing authorisation
Amvuttra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Singapore
Frequently asked questions
Is Amvuttra approved in Singapore?
Yes. HSA authorised it on 13 June 2022.
Who is the marketing authorisation holder for Amvuttra in Singapore?
ALNYLAM PHARMS INC holds the Singaporean marketing authorisation.